<DOC>
	<DOCNO>NCT01131026</DOCNO>
	<brief_summary>Today , although triple treatment clarithromycin accept primary treatment Helicobacter pylorus infection eradication well tolerate , eradication decrease 65 % . However , eradication result TRIOL treatment levofloxacin expect 75 % high . If target result reach , conclude TRIOL treatment levofloxacin alternative triple treatment clarithromycin primary treatment .</brief_summary>
	<brief_title>Efficacy Safety Evaluation Levofloxacin Triple Therapy Helicobacter Pylori Eradication</brief_title>
	<detailed_description>The primary end point study appoint `` Helicobacter pylorus infection eradication TRIOL treatment '' secondary end point `` safety '' . The study involve investigation efficacy safety triple treatment consist 500 mg levofloxacin , 1000 mg amoxicillin 30 mg lansoprazole Helicobacter pylorus eradication 60 patient Helicobacter pylori infection .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Consenting endoscopy Signing inform consent form Not receive Helicobacter pylori eradication treatment Showing Helicobacter pylori infection rapid urease test and/or Giemsa stain Being old 18 year age Being young 18 year age Receiving H. pylori eradication treatment previously Having gastrectomy vagotomy medical history Having gastric malignancy , include adenocarcinoma lymphoma Having severe malignant disease Previously allergic reaction antibiotic ( amoxicillin , levofloxacin ) proton pump inhibitor ( lansoprazole ) Using prompt pump inhibitor ( lansoprazole ) antibiotic ( amoxicillin , clarithromycin , levofloxacin ) last 4 week Having active upper GI bleeding last week Being pregnant lactate Taking long term high dosage aspirin , corticosteroid NSAIDs last 4 week Taking antibiotic proton pump inhibitor study medication study period Taking antacid and/or H2blockers study period Taking bismuth compound within four week prior study period Having dysphasia vomit major symptom Having psychiatric , neurological , behavioral disorder may interfere conduct interpretation study Having severe concomitant disease cardiovascular , pulmonic , hepatic , renal , hematological , lymphatic , metabolic , endocrine system . Having know uncontrolled hypertension Being immunocompromised Showing clinically significant abnormal vital sign Having clinically significant abnormal ECG finding Presenting clinically significant abnormal laboratory data screening , abnormal laboratory value could interfere assessment safety Being expose investigational drug within 30 day prior screen Having know hypersensitivity contraindication fluoroquinolones . Having current diagnosis know history substance abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>levofloxacin</keyword>
	<keyword>amoxicillin</keyword>
	<keyword>lansoprazole</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
	<keyword>triple therapy</keyword>
</DOC>